Physician Profile

<< Previous Physician | Return to Search Results | New Search | Next Physician >>

Nancy DeMore, MD


Department of Surgery
    Division of Surgical Oncology and Endocrine Surgery

Cancer Services, Multidisciplinary Clinical Services, Breast Center, Surgical Oncology
Surgery, Endocrine Surgery
Surgery, General Surgery
Surgery, Surgical Oncology
Cancer Services, Divisional Programs, General Surgery/Surgical Oncology

General surgical oncology, breast diseases, breast surgery.
Clinical Appointment Phone:  919-966-0381

Nancy DeMore, MD

Surgery - Board Certified  (2000)

Education and Training
Medical School: MD, Chicago Medical School, Chicago, IL, 1991
Residency: Boston University Medical Center, Boston, MA, 1991 - 1993
Area: General Surgery
Fellowship: Harvard Medical School, Boston, MA, 1993 - 1996
Area: Surgery
Residency: Boston University Medical Center, Boston, MA, 1996 - 1999
Area: General Surgery
Fellowship: Memorial Sloan-Kettering Cancer Center, New York, NY, 1999 - 2001
Area: Surgical Oncology

  1. Loss of detectable TRH receptor and decreased prolactin production in cultured isolates of GH pituitary tumor cells.
    Authors: Klauber N
    The New York Academy of Sciences, New York, NY, 1987

  2. Transfer of thyrotopin-releasing hormone receptors to receptor-deficient GH12C1 rat pituitary tumor cells.
    Authors: Klauber N
    Eastern New England biological Conference, 45th Annual Meeting, Weston, MA, 1987

  3. Gastric duplication cyst encircled by an accessory pancreatic lobe: Case report and review of literature.
    Authors: Klauber N
    Pediatric Surgery Resident's Conference, 15th Annual Meeting, Brooklyn, NY, 1994

  4. Growth suppression of a human breast carcinoma in vivo and inhibition of angiogenesis in vivo by the endogenous estrogen metabolite 2-methoxyestradiol.
    Authors: Klauber N
    American College of Surgeons, 81st Annual Clinical Congress, New Orleans, LA, 1995

  5. 2-methoxyestradiol is an inhibitor of angiogenesis.
    Authors: Klauber N
    New England Cancer Society, Boston, MA, 1996

  6. The angiogenesis inhibitor AGM-1470 blocks fetal development in mice.
    Authors: Klauber N
    American College of Surgeons, 82nd Annual Clinical Congress, San Francisco, CA, 1996

  7. Critical components of the female reproductive system are inhibited by the angiogenesis inhibitor AGM-1470.
    Authors: Klauber N
    New England Cancer Society, New Haven, CT, 1998

  8. Sentinel lymph node biopsy is indicated in patients with high-grade DCIS and DCIS with microinvasion.
    Authors: Klauber N
    Society of Surgical Oncology, New Orleans, LA, 2000

  1. New activity of spironolactone: inhibition of angiogenesis in vitro and in vivo.
    Authors: 1. Klauber N, Browne F, Anand-Apte B, D'Amato RJ.
    Circulation 94:2566-2571, 1996

  2. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and Taxol.
    Authors: 2. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ.
    Cancer Research 57:81-86, 1997

  3. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.
    Authors: 3. Arbisor JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownless M, Flynn E, Parangi S, Byers HR, Folkman J.
    Proceedings of National Academic Science USA 94:861-866, 1997

  4. Critical components of the female reproductive system are suppressed by the angiogenesis inhibitor AGM-1470.
    Authors: 4. Klauber N, Rohan RM, Flynn E, D'Amato RJ.
    Nature Medicine 3:443-446, 1997

  5. Curcumin is an in vivo inhibitor of angiogenesis.
    Authors: 5. Arbisor JL, Klauber N, Rohan R, Van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR.
    Molecular Medicine 4:376-383, 1998

  6. The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice.
    Authors: 6. Arbiser JL, Panigrathy D, Klauber N, Rupnick M, Flynn E, Udagawa T, D'Amato RJ.
    Journal of American Academic Dermatology 40:925-929, 1999

Physician Referral:
You can request a physician referral by calling UNC HealthLink at (919) 966-7890,
8:30 a.m. to 5 p.m., Monday through Friday.